USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/15958
Title: Lactobacillus rhamnosus, and Lactobacillus reuteri with estriol in the treatment of vaginal dysbiosis pathologies
Authors: Profire, Liliana
Niguleanu, Adriana
Corolcova, Natalia
Burac, Mihaela
Cotelea, Veronica
Keywords: bacterial vaginosis;Lactobacillus rhamnosus;vaginal flora;estriol
Issue Date: 2021
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: PROFIRE, Liliana, NIGULEANU, Adriana, COROLCOVA, Natalia, BURAC, Mihaela, COTELEA, Veronica. Lactobacillus rhamnosus, and Lactobacillus reuteri with estriol in the treatment of vaginal dysbiosis pathologies. In: The Moldovan Medical Journal. 2021, vol. 64, no 1, pp. 35-40. ISSN 2537-6381. DOI: 10.5281/zenodo.4527082
Abstract: Abstract. Background: A healthy vagina is characterized by hydrogen peroxide and acid-producing lactobacilli, which are crucial to maintaining the physiological vaginal ecosystem and their depletion speed up bacterial overgrowth with pH elevation, sialidase, and amine production, leading to the observed signs and symptoms of vaginal dysbiosis. An effective treatment should be combined of lactobacillary flora and low doses of estrogen to maintain the physiology of the vaginal epithelium. Material and methods: This is a prospective randomized study that included 218 patients, who were divided into 2 groups according to the treatment regimen, performed between October 2018 and December 2019 at the Department of Obstetrics and Gynecology of Nicolae Testemitanu State University of Medicine and Pharmacy. Patients selected were divided into L1 (120 patients assigned to treatment with the combination of two microorganisms Lactobacillus rhamnosus and Lactobacillus reuteri with estriol 0.03 mg vaginal pessaries) and L2 (98 patients who were given Lactobacillus rhamnosus in vaginal capsules). The treatment regimen for both groups was the same – 1 pessary or 1 capsule once in 24 hours, in the evening, for 12 days. Patients were evaluated before treatment (visit 1) and on day 13 of treatment (visit 2) and 1 month after the end of treatment (visit 3). Results: Of the 120 women included in the study in the first group and 98 in the second group, a significant improvement (normocenosis) according to the research physician and patients were found in 93.3% (112) patients of group 1 and 71.4% (70) patients in group 2, satisfactory improvement (consistent with the intermediate type of biocenosis) in 5% (6) patients of group 1 and 15.3% (14) patients from group 2, unsatisfactory result 1.7% (2) patients from group 1 and 13.3% (13) of patients of group 2 (later relapse was noted in these patients). Conclusions: Probiotic treatment with vaginal Lactobacillus rhamnosus, Lactobacillus reuteri and low doses of estriol seems to be useful in hindering bacteria growth especially after antibiotic therapy; therefore this intervention may be considered a new prophylactic treatment for preventing recurrence of bacterial vaginosis, in particular in high-risk patients.
metadata.dc.relation.ispartof: The Moldovan Medical Journal
URI: http://moldmedjournal.md/wp-content/uploads/2021/02/64-1-Mold-Med-Journal-version-3.pdf
http://repository.usmf.md/handle/20.500.12710/15958
ISSN: 2537-6381
2537-6373
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 1, March 2021



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback